Rituximab Consultation

The National Institute for Clinical Excellence has invited the Lauren Currie Twilight Foundation to a Rituximab consultation in July 2012.  The Foundation is delighted that NICE are focusing on Vasculitis and effective treatments.   The consultation  and assessment from NICE of Vasculitis treatments will have a big impact on patient diagnosis and care and is welcomed by patients across the United Kingdom. The consultation will focus on Rituximab being used with steroids for the treatment of anti-neutrophil cytoplasmic antibody-associated Vasculitis.

The LCT Foundation will take part in the consultation and keep the website updated on progress.

More Articles

22nd May 2023
Giant Cells in GCA update
Read Article
6th May 2023
Vasculitis Awareness Month 2023
Read Article
21st December 2022
The LCTF Tartan
Read Article